Skip to content
2000
Volume 17, Issue 3
  • ISSN: 1871-529X
  • E-ISSN: 2212-4063

Abstract

Introduction: Patients with severe thrombocytopenia are presumed to be at increased risk for bleeding, and consequently it has been a standard practice for the past four decades to give allogeneic platelet transfusions to severely thrombocytopenic patients as supportive care. Platelet transfusions may be given either prophylactically to reduce the risk of bleeding, in the absence of clinical hemorrhage (prophylactic transfusions), or to control active bleeding when present (therapeutic transfusions). Conclusion: Here we review the structure and function of platelets and discuss the mechanisms of alloimmunization to platelet transfusion.

Loading

Article metrics loading...

/content/journals/chddt/10.2174/1871529X18666171227152937
2017-12-01
2025-09-13
Loading full text...

Full text loading...

/content/journals/chddt/10.2174/1871529X18666171227152937
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test